» Authors » Kyong-Cheol Ko

Kyong-Cheol Ko

Explore the profile of Kyong-Cheol Ko including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 13
Citations 102
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ha S, Kim J, Seo H, Kim L, Yi Y, Seo S, et al.
ACS Nano . 2025 Feb; 19(5):5131-5145. PMID: 39893588
The development of nanodrugs targeting multidrug-resistant bacteria, while sparing the beneficial constituents of the microbiome, has emerged as a promising approach to combat disease and curb the rise of antimicrobial...
2.
Seo S, Kim K, Kim S, Ko K, Kim W, Lee K, et al.
Adv Sci (Weinh) . 2025 Jan; 12(9):e2411849. PMID: 39807576
Molecular diagnosis limitations, including complex treatment processes, low cost-effectiveness, and operator-dependent low reproducibility, interrupt the timely prevention of disease spread and the development of medical devices for home and outdoor...
3.
Shahzad K, Hasan A, Hussain Naqvi S, Parveen S, Hussain A, Ko K, et al.
Chemosphere . 2024 Dec; 370():143936. PMID: 39667528
The increase in nano/microplastics (NPs/MPs) from various everyday products entering aquatic environments highlights the urgent need to develop mitigation strategies. Biochar (BC), known for its excellent adsorption capabilities, can effectively...
4.
Yoo M, Eom H, Im W, Lee B, Han K, Seo J, et al.
Phytomedicine . 2024 Sep; 134:156014. PMID: 39241386
Background: Since the onset of the coronavirus disease 2019 (COVID-19) pandemic, remarkable advances have been made in vaccine development to reduce mortality. However, therapeutic interventions for COVID-19 are comparatively limited...
5.
Park S, Seo J, Han K, Lee B, Lee C, Kim B, et al.
Vaccine X . 2024 Sep; 20:100545. PMID: 39221182
The coronavirus disease 2019 (COVID-19) emerged as a major global health crisis, posing significant health, economic, and social challenges. Vaccine development has been a crucial response to the severe-acute-respiratory-syndrome-related coronavirus-2...
6.
Lim D, Kim K, Kim H, Ko K, Song J, Choi J, et al.
Oncotarget . 2017 May; 8(23):37550-37560. PMID: 28473665
The anticancer strategy underlying the use of immunotoxins is as follows: the cancer-binding domain delivers the toxin to a cancer cell, after which the toxin enters and kills the cell....
7.
Ko K, Lee B, Cheong D, Han Y, Choi J, Song J
J Microbiol Biotechnol . 2015 Sep; 25(11):1835-41. PMID: 26323268
A cell surface display system for heterologous expression of the multifunctional cellulase, CelEx-BR12, in Escherichia coli was developed using truncated E. coli outer membrane protein C (OmpC) as an anchor...
8.
Cheong D, Ko K, Han Y, Jeon H, Sung B, Kim G, et al.
Biotechnol Bioeng . 2014 Oct; 112(4):822-6. PMID: 25323933
Recent studies using heterologous protein expression systems suggest that synonymous codons affect not only the expression but also the properties of the expressed protein. However, practical application of this information...
9.
Ko K, Lee J, Han Y, Choi J, Song J
Biochem Biophys Res Commun . 2013 Nov; 441(3):567-72. PMID: 24184482
Metagenomic resources representing ruminal bacteria were screened for novel exocellulases using a robotic, high-throughput screening system, the novel CelEx-BR12 gene was identified and the predicted CelEx-BR12 protein was characterized. The...
10.
Ko K, Han Y, Cheong D, Choi J, Song J
J Microbiol Methods . 2013 Jul; 94(3):311-6. PMID: 23892060
Exocellulases play a key role in cleaving the accessible ends of cellulose molecules to release soluble glucose and cellobiose. To date, there have been no screens for exocellulase owing to...